University of North Carolina, Chapel Hill: Barrett Esophagus trials
The registry lists 10 Barrett Esophagus studies with University of North Carolina, Chapel Hill as lead sponsor. 2 are open to participants now and 2 have results posted.
Phase 4 1No phase 9(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Efficacy of Potassium-Competitive Acid Blockers in Barrett's Esophagus (PCAB BE Study)Not yet recruitingNCT07788742Phase 4
- University of North Carolina (UNC) Barrett's Esophagus and Esophageal Cancer BiorepositoryEnrolling by invitationNCT02427269
- Patient Acceptance and Preference Among Screening Modalities for Detection of Barrett's EsophagusCompletedNCT04301986Not applicableResults posted
- Non-Endoscopic Surveillance for Barrett's Esophagus Following Ablative TherapyCompletedNCT02106910Not applicableResults posted
- Utility Of Mutational Load As A Predictor For Endoscopic Treatment Response In Barrett's EsophagusCompletedNCT04316975Not applicable
- Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)Active, not recruitingNCT03554356Not applicable
- Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient ManagementCompletedNCT02075905
- Prevalence of Dysplasia of the Gastric CardiaCompletedNCT01787864
- Racial Disparity in Barrett's EsophagusCompletedNCT01374074
- Is the Neosquamous Epithelium "Normal" Following Endoscopic Ablation of Dysplastic Barrett's Esophagus?CompletedNCT01373125